Award Number : W 81 XWH - 08 - 1 - 0660 TITLE : TPD 52 : A Novel Vaccine Target for Prostate Cancer

s: • AACR annual meeting accepted 1/26/2010: “Inhibition of Tumor Formation in Mice following Vaccination with DNA Encoding a Novel Xenogeneic Tumor Associated Auto-Antigen”. Jennifer D. Bright, Heather N. Schultz, and Robert K. Bright, Departments of Microbiology & Immunology and Urology, Texas Tech University Health Sciences Center, Lubbock, Texas • ImPact meeting, accepted 8/26/2010: “Prostate Cancer Vaccines Targeting Over-Expressed Self-Oncoantigens”. Robert K. Bright, Texas Tech University Health Sciences Center; Jennifer D. Bright, Texas Tech University Health Sciences Center; Heather N. Schultz, University of Texas at Austin ; Jennifer A. Byrne, The University of Sydney Discipline of Paediatrics and Child Health, Childrens Hospital at Westmead, NSW, Australia.